B. Metzler Seel. Sohn & Co. Ag Bio Techne Corp Transaction History
B. Metzler Seel. Sohn & Co. Ag
- $9.49 Billion
- Q2 2024
A detailed history of B. Metzler Seel. Sohn & Co. Ag transactions in Bio Techne Corp stock. As of the latest transaction made, B. Metzler Seel. Sohn & Co. Ag holds 3,997 shares of TECH stock, worth $319,400. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,997
Previous 3,785
5.6%
Holding current value
$319,400
Previous $266,000
7.52%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding TECH
# of Institutions
604Shares Held
153MCall Options Held
171KPut Options Held
56.9K-
Vanguard Group Inc Valley Forge, PA18.2MShares$1.45 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY15MShares$1.2 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD8.53MShares$681 Million0.07% of portfolio
-
State Street Corp Boston, MA6.3MShares$504 Million0.02% of portfolio
-
Bamco Inc New York, NY4.78MShares$382 Million1.0% of portfolio
About BIO-TECHNE Corp
- Ticker TECH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,222,600
- Market Cap $3.13B
- Description
- Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...